Skip to content
Briefings are running a touch slower this week while we rebuild the foundations.See roadmap
UK Startups and Innovation
7JUN

UK Horizon Europe share rebounds to 9.3%

3 min read
10:09UTC

DSIT data published on 5 June show the UK's Horizon Europe funding share rose to 9.3% in 2024 from 5.8% a year earlier, with the applied-research strand up 68%, a genuine recovery that still sits below the pre-Brexit peak.

TechnologyDeveloping
Key takeaway

UK Horizon Europe recovery is real and feeds the spinout pipeline, but sits below the 2018/19 peak.

DSIT published UK participation figures for the EU's Horizon Europe research programme on Friday 5 June. The UK's share of funding won rose to 9.3% in 2024, from 5.8% in 2023, worth €994m, with its share of proposals climbing from 18.9% to 24.1%. The department described the result as a partial recovery toward late Horizon 2020 levels, still below the 2018/19 peak. 1

Horizon Europe is the EU's flagship research programme; the UK re-associated in 2024 after Brexit exclusion. The sharpest move sits in Pillar 2, the strand funding industrial and applied collaborative research that feeds university tech-transfer offices and spinouts. The UK's Pillar 2 share rose 68% year on year, from 3.7% to 6.2%. The part of the recovery most likely to surface later as commercial IP is also the part growing fastest.

DSIT's own framing keeps the ceiling in view. Re-association has reopened the collaborative-funding pipe, but it is not yet running at pre-Brexit volume. The France science alliance signed in May is the bilateral hedge that runs alongside the multilateral programme, a second channel for the same collaborative research while Horizon participation climbs back toward where it was.

Deep Analysis

In plain English

Horizon Europe is the European Union's main research funding programme, with a total budget of roughly €95bn for 2021-2027. The UK was excluded from it after Brexit until re-association in early 2024. In 2023, the UK's share of Horizon funding was 5.8%. In 2024, it recovered to 9.3%, meaning UK researchers won €994m of grants. The applied-research strand (Pillar 2) recovered fastest, growing 68% year-on-year. However, DSIT itself describes this as a partial recovery: before Brexit, the UK had a larger share. Getting back to pre-Brexit levels requires winning a higher proportion of the proposals that UK researchers are submitting, which depends partly on Brussels relationships that were disrupted during three years of exclusion.

Deep Analysis
Root Causes

Pillar 2 (industrial research consortia) recovered faster than Pillar 1 (curiosity-driven ERC) for structural reasons. Pillar 2 projects involve industrial consortia where UK companies remain commercially attractive partners regardless of political status. A German automotive manufacturer running a battery electrolyte consortium has direct commercial reasons to include a UK material-science team even under associate rules.

ERC individual grants differ: UK researchers compete head-to-head against EU nationals in peer-review panels where the 2021-2023 exclusion period broke the informal network ties that referees use to assess applicants. Rebuilding those networks takes the length of a grant cycle, roughly 5-7 years, which is why the Pillar 1 recovery lags.

What could happen next?
  • Consequence

    Pillar 2 grants awarded in 2024 will produce commercial IP and spinout companies in 2029-2032. The 68% year-on-year growth means the UK spinout pipeline from Horizon is growing again after a four-year gap.

  • Risk

    The UK's 24.1% proposal share suggests strong research intent but a still-recovering award conversion rate. If consortium-formation biases persist, the actual funding return may plateau before recovering to pre-Brexit levels.

First Reported In

Update #7 · OQC's £260m sets European quantum record

UK Tech News· 7 Jun 2026
Read original
Causes and effects
This Event
UK Horizon Europe share rebounds to 9.3%
The 68% jump in Pillar 2 is a leading indicator for future UK tech transfer and spinout volume, rather than a diplomatic recovery metric.
Different Perspectives
Spanish state finance (COFIDES, CDTI)
Spanish state finance (COFIDES, CDTI)
Spain's COFIDES and CDTI have co-invested alongside UK deep-tech rounds in prior cycles and track the British Business Bank's direct-investment activity as a benchmark for state-capital deployment in innovation. BBB's two direct co-investments in one week set a pace reference for Iberian equivalents.
UK city-region mayors (Greater Manchester, West Midlands, Liverpool)
UK city-region mayors (Greater Manchester, West Midlands, Liverpool)
The LIPF devolution from 2027 hands seven mayors direct grant allocation, cutting Whitehall from the approval chain. Liverpool's £23.7m first allocation to AI research programmes shows the mechanism working before the formal devolution date.
Japanese strategic investors
Japanese strategic investors
OQC already generates hardware revenue in Japan, one of four countries where its quantum systems are live. Japan's national quantum strategy targets 2030 for commercial adoption; a UK supplier with active Japanese contracts is a supply-chain asset before domestic fabrication scales.
European venture capital (Highland Europe, Plural, Index Ventures)
European venture capital (Highland Europe, Plural, Index Ventures)
European funds led or co-led three of the week's rounds: Highland Europe and Index Ventures on Wordsmith, Plural on Gigaton, Singular on Apoha. Continental LP capital is backing UK deep-tech and software at Series A and B without waiting for US validation.
US growth investors
US growth investors
Bullhound Capital's £260m OQC lead and DN Capital's £14.9m Airspeed ticket show US-linked growth capital treating UK quantum and AI as credible revenue bets rather than science projects. The OQC round is the largest-ever private quantum raise in Europe, suggesting US allocators have moved past post-Brexit risk discounts on UK technology.
UK Government (DSIT)
UK Government (DSIT)
DSIT published Horizon recovery figures, Global Talent Fund recruitment numbers and the LIPF devolution announcement on overlapping days in June, framing a triple proof-point for its innovation agenda. The co-timing signals a deliberate narrative strategy linking talent, funding geography and international re-engagement into a single story.